CG
NNVC icon

Cutler Group’s NanoViricides NNVC Stock Holding History

Cutler Group’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,200
Closed -$1K – 5791
2021
Q4 		$1K Sell
1,200
-14,300
-92% -$65.1K ﹤0.01% 5073
2021
Q3 		$14K Buy
+15,500
New +$64.6K ﹤0.01% 3659
2020
Q4 		– Sell
-500
Closed -$2K – 5287
2020
Q3 		$2K Buy
+500
New +$2.74K ﹤0.01% 4085

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cutler Group's NNVC Position: Q3 2022 in Review

Cutler Group sold out of NanoViricides (NNVC) in Q3 2022, closing a stake of 1,100 shares — an estimated $2K sold.

Cutler Group first reported a position in NNVC in Q3 2020 and held it in 5 quarters. The position peaked at $15K in Q3 2021. 31 funds tracked by Wall St. Rank hold NNVC as of Q3 2022.

  • Cutler Group reported no remaining NanoViricides position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 1,100 NanoViricides shares in Q3 2022, an estimated $2K.
  • Cutler Group first reported a position in NanoViricides in Q3 2020 and held it in 5 quarters.
  • Cutler Group's NanoViricides position peaked at $15K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held NanoViricides as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.